All lobbying filings
BALLARD PARTNERS
BALLARD PARTNERS filed a Q4 amendment for MADRIGAL PHARMACEUTICALS, INC. on January 14, 2026, reporting no lobbying activity.
Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q4 amendmentNo activity
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 14, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Lobbying activity
0
No itemized activity in this filing.